Piccart, M J <br/><br/>
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 2001 
 - 3103-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.12.3103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Belgium--epidemiology<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Prognosis<br/>Proportional Hazards Models<br/>Statistics, Nonparametric<br/>Survival Rate